Dendritic cells injected via different routes induce immunity in cancer patients

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 4254-4259

  Fong, L ^a   Brockstedt, D ^a   Benike, C ^a   Wu, L ^a   Engleman, E G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; B7 ANTIGEN; CD2 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; HERMES ANTIGEN; PADGEM PROTEIN; TUMOR VACCINE;

ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNIZATION; CANCER PATIENT; CELL CULTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; LYMPHOID TISSUE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0035869523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.4254     Document Type: Article

References (28)

1. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses
2. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells
3. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes
4. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
5. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo
6. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
7. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
8. Dendritic cells in cancer immunotherapy
9. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
10. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
11. Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment
12. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
13. In vivo migration of dendritic cells differentiated in vitro: A chimpanzee model
14. Migration of human dendritic cells after injection in patients with metastatic malignancies
15. Technical details of intraoperative lymphatic mapping for early stage melanoma
16. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
17. Dendritic cells and the control of immunity
18. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance
19. A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood
20. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines
21. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells
22. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties
23. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
24. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
25. Prospects for adoptive T cell therapy
26. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration
27. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery
28. Clinical trials of antibody therapy